August, 6, 2014
Attorney General Kane announces Pa. to receive $1.3 million in Pfizer settlement
HARRISBURG - Attorney General Kathleen G. Kane announced today that her office and 41 other state attorneys general have reached a $35 million settlement with Pfizer Inc.
In the settlement, Pfizer, who is the parent company of Wyeth Pharmaceuticals Inc., agrees to resolve allegations that Wyeth unlawfully promoted Rapamune.
Attorney General Kane said that the off-label marketing case provides for a payment to Pennsylvania of $1,367,403.76 along with substantial injunctive relief. The Pennsylvania Office of Attorney General was a member of the multi-state action's executive committee.
Rapamune is an immunosuppressive drug currently approved by the United States Food and Drug Administration as a prophylactic for organ rejection after kidney transplant surgery.
The complaint and consent judgment filed today allege that Wyeth violated state consumer protection laws by misrepresenting the uses and benefits of Rapamune. This included allegedly making representations related to:
The consent judgment requires Pfizer to ensure that its marketing and promotional practices do not unlawfully promote Rapamune or any Pfizer product.
Specifically, Pfizer shall not, among other things:
The executive committee was led by Oregon and Texas, which, in addition to Pennsylvania, also included the attorneys general from California, Florida, Illinois, Maryland, New York, and North Carolina.
State attorneys general also participating in the settlement include Alabama, Arizona, Arkansas, Colorado, Delaware, District of Columbia, Georgia, Hawaii, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, North Dakota, Ohio, Oklahoma, South Dakota, Tennessee, Utah, Virginia, Washington, and Wisconsin.
The agreement was filed in Commonwealth Court by Chief Deputy Attorney General Thomas M. Devlin and Deputy Attorney General Nicole L. VanOrder of the Health Care Section.